RV

Remiges Ventures

North America, Massachusetts, United States, Cambridge

Description

Remiges Ventures is a venture capital firm that focuses on groups and businesses in the Japanese academia and pharmaceutical industry.

Investor Profile

Remiges Ventures has made 17 investments, with 1 in the past 12 months and 71% as lead.

Stage Focus

  • Series A (47%)
  • Series B (29%)
  • Seed (18%)
  • Series C (6%)

Country Focus

  • United States (41%)
  • Japan (24%)
  • Germany (18%)
  • Israel (6%)
  • France (6%)
  • Canada (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Pharmaceutical
  • Medical Device
  • Clinical Trials
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Remiges Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
ANRI
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 2
QB Capital
Asia, Fukuoka, Japan, Fukuoka
Co-Investments: 2
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 3
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 1
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 2
Dementia Discovery Fund
Europe, England, United Kingdom, London
Co-Investments: 1
UntroD Capital
Asia, Tokyo, Japan, Sumida
Co-Investments: 2

What are some of recent deals done by Remiges Ventures?

Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series CApr 16, 2025
Amount Raised: $115,000,000
KisoJi Biotechnology

Laval-ouest, Quebec, Canada

KisoJi Biotechnology is a biotechnology company focused on healthcare and life sciences for research and development industries.

BiotechnologyLife ScienceMedicalTherapeutics
Series BDec 2, 2024
Amount Raised: $40,579,533
Cyrano Therapeutics

Washington, District of Columbia, United States

Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.

Health CareMedicalMedical DeviceTherapeutics
Series BJan 16, 2024
Amount Raised: $9,000,000
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
Series ADec 15, 2023
Amount Raised: $4,221,636
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
Series AJun 5, 2023
Amount Raised: $9,109,510
Kupando

Schönefeld, Brandenburg, Germany

Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.

Biotechnology
Series ASep 26, 2022
Amount Raised: $12,506,073
LUCA Science

Tokyo, Tokyo, Japan

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

BiotechnologyHealth CarePharmaceutical
Series BJun 6, 2022
Amount Raised: $29,203,600
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
SeedFeb 3, 2022
Amount Raised: $2,566,121
Viage Therapeutics

San Francisco, California, United States

Viage Therapeutics is a biotech company that develops therapeutics that stimulates the central nervous system via the gut-brain axis.

BiotechnologyClinical TrialsMedical
SeedJan 6, 2022
Amount Raised: $10,000,000
Capacity Bio

Palo Alto, California, United States

Capacity Bio is a therapeutics company that is focused on mitophagy.

BiotechnologyLife ScienceMedical
SeedJan 1, 2022